Yesterday the Food and Drug Administration (FDA) announced it has approved plasma from recovered COVID-19 patients to be used as a hospital-based treatment for the novel coronavirus under an emergency use authorization (EUA).The move was announced during an unscheduled press conference by President Donald Trump yesterday evening, just a day before the Republican National Convention begins.
Critics said Trump portrayed the EUA as a treatment breakthrough to boost support as the Nov 3 presidential election draws nearer."Based on the science and the data, the FDA has made the independent determination that the treatment is safe and very effective," Trump said.
Read more on cidrap.umn.edu